Clover Health Investments, Corp. (NASDAQ:CLOV) CEO Sells $276,000.00 in Stock

Clover Health Investments, Corp. (NASDAQ:CLOV) CEO Brady Patrick Priest sold 75,000 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $3.68, for a total transaction of $276,000.00. Following the completion of the sale, the chief executive officer now owns 2,418,151 shares in the company, valued at $8,898,795.68. The trade was a 3.01 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Clover Health Investments Price Performance

Clover Health Investments stock opened at $3.64 on Monday. The firm’s 50 day simple moving average is $4.08 and its 200-day simple moving average is $3.62. The company has a market cap of $1.82 billion, a P/E ratio of -18.20 and a beta of 2.00. Clover Health Investments, Corp. has a fifty-two week low of $0.61 and a fifty-two week high of $4.87.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in CLOV. Graypoint LLC purchased a new position in Clover Health Investments during the fourth quarter valued at approximately $632,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in Clover Health Investments during the third quarter valued at approximately $1,228,000. Connor Clark & Lunn Investment Management Ltd. grew its position in Clover Health Investments by 75.7% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,128,171 shares of the company’s stock valued at $3,181,000 after purchasing an additional 485,987 shares in the last quarter. JPMorgan Chase & Co. purchased a new position in Clover Health Investments during the third quarter valued at approximately $448,000. Finally, State Street Corp grew its position in Clover Health Investments by 65.0% during the third quarter. State Street Corp now owns 2,189,380 shares of the company’s stock valued at $6,174,000 after purchasing an additional 862,621 shares in the last quarter. 19.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CLOV. Craig Hallum began coverage on shares of Clover Health Investments in a report on Tuesday, December 17th. They issued a “buy” rating and a $6.00 target price on the stock. Canaccord Genuity Group boosted their target price on shares of Clover Health Investments from $4.20 to $4.50 and gave the stock a “buy” rating in a report on Monday, March 3rd.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.